GenAssist reposted this
Chief Executive Officer | MTI '23 | CDL '23 | mHUB '22 | Arch Grants '22 | 2021 Inno Under 25
I'm thrilled to announce that last month, GenAssist secured a non-dilutive $20,000 award from Hologic, Inc., a trailblazer in women's health medical devices and recognized as one of the 100 Fastest-Growing Companies and among the top 40 Best Large Workplaces in Health Care by Forbes. We're gearing up to expand our MyoMatrix muscle-regenerating biomaterial platform with an innovative product that addresses a critical need in women's health. Gabriel Haas and I are eager to kick off our collaboration with the Hologic, Inc. team, and we're especially stoked to work alongside Jim Duronio!
Thank you to the hundreds of #medtech #entrepreneurs, #LifeSciences experts, investors, sponsors and community members who joined us last night for the BIGGEST #200KChallenge in years. For the first time in $200K Challenge history, we had a SOLD OUT event. The iHub could barely contain the innovative ideas, energy and attendees who spent their evening in Lowell. A massive thank you to the sponsors who help make the $200K Challenge possible, and provide resources and funding to the finalists. Your ongoing support continues to help us drive healthcare innovation around the world. And finally, congratulations to this year's Challenge winners! Your stellar pitch presentations wowed the judges, leading to one of the closest competitions we've seen. Your overall determination to solve healthcare challenges is inspiring. We can't wait to where you are headed next! The 2024 Challenge winners: 🥇 First Place: Relavo, for their disinfecting connection device that reduces infection risk associated with dialysis. 🥈 Second Place: EndoShunt Medical, for their temporary, minimally invasive hemorrhage control device that creates a size-adjustable channel inside the IVC or aorta. 🥉 Third Place: Neuraura, for their device that uses low-frequency electrostimulation to treat symptoms associated with polycystic ovarian syndrome (PCOS). 💰 M2D2 $25K Cash Award: Nucyrna Therapeutics, for their oligonucleotide platform enabling next-gen RNA-targeting therapeutics for CNS disorders. 💰 Massachusetts Life Sciences Center $50K Award: Lilypad Health, for their menstrual pad add-on that screens for diseases high-risk HPV, HIV, and other STDs. These Finalists won a total of $200K in in-kind support from our event sponsors: ➡️ AIRS Medical: Awards from Inertia Product Development and bene : studio ➡️ Armor Medical Inc: Award from MPR Associates, Inc. ➡️ Calliope Biophysics: Award from Johnson & Johnson MedTech ➡️ Cellens Inc: Award from bene : studio ➡️ EndoShunt Medical: Awards from Asahi Intecc USA, Inc., Mintz, Prime Path Medtech™, and bene : studio. ➡️ GenAssist: Award from Hologic, Inc. ➡️ Lilypad Health: Award from Argenta Advisors, Inc. ➡️ Neuaura: Award from PrimePath. ➡️ Nucyrna Therapeutics: Award from Amgen. ➡️ Relavo Medical: Award from Prime Path Medtech. Congratulations again to these hardworking #Startups and entrepreneurs!